Therapeutic Solutions International Spin-Off Campbell Neurosciences Initiates Pilot Implementation of Campbell Score™ with California Concierge Medical & Wellness Inc.

Rhea-AI Summary

Therapeutic Solutions International (TSOI) has initiated pilot implementation of the Campbell Score™ blood-based suicide prediction marker, in collaboration with Concierge Medical & Wellness Inc in San Diego. This innovative tool aims to assist psychiatrists in quantifying suicide risk and is based on positive clinical trial results indicating higher scores for patients with suicidal tendencies. The company plans to further develop this tool with potential FDA clearance and insurance reimbursement in the future.

Positive

• Pilot implementation of Campbell Score™ in collaboration with Concierge Medical & Wellness Inc.
• Positive clinical trial results supporting Campbell Score™ for assessing suicide risk.
• Future plans for FDA clearance and insurance reimbursement for the Campbell Score™.

Negative

• None.

ELK CITY, Idaho, July 2, 2021 /PRNewswire/ -- Therapeutic Solutions International, Inc., (OTC Markets: TSOI), announced today medical implementation of its Campbell Score™ blood-based suicide prediction marker in collaboration with the premiere San Diego personalized health center, Concierge Medical & Wellness Inc.

The Campbell Score™ was subject of a clinical trial¹ which demonstrated patients with suicidal tendencies have a higher rating on the novel scale².  To the knowledge of the Company, the Campbell Score™ is the only subjective instrument in development capable of assisting psychiatrists in guiding frequency and intensity of their interventions.

"The Campbell Score™ is named after my mother, Kathleen Campbell, who was a victim of suicide. The goal of our Company is to create a world without suicide. The first step in this is quantifying risk of suicide in a scientific and objective manner," said Kalina O'Connor, President and CEO of Campbell Neurosciences. "We are extremely grateful that Chief Medical Officer, Dr. James Veltmeyer, volunteered for us to use his medical practice as the original launching pad for the Campbell Score™. Through initial implementation on a pilot basis, we can work on kinks in a real-life environment while we are concurrently working on launching a pivotal trial to apply for FDA clearance and eventual insurance reimbursement."

"Kalina O'Connor is a true inspiration. It is extremely rare to work with someone who can translate the suffering of a personal tragedy into a company that has a real shot at changing the way suicide is perceived by the medical community," said Dr. James Veltmeyer, Chief Medical Officer of the Company and Owner of California Concierge Medical & Wellness Inc. "I am proud to put my name and reputation behind this completely revolutionary approach to a terrible epidemic which is the number two cause of death in young people."

"At the end of the day, we are all in the field of biomedical sciences because we want to advance science and save lives," said Timothy Dixon, President and CEO of Therapeutic Solutions International and Chairman of Campbell Neurosciences. "It brings great joy to me and our shareholders that this new tool developed by our spin-off company is entering medical practice.  I applaud Ms. O'Connor for her perseverance and leadership skills in taking this small step with Dr. Veltmeyer that we hope will be the basis for seeing suicide as a disease and not a choice."

About Therapeutic Solutions International, Inc.
Therapeutic Solutions International is focused on immune modulation for the treatment of several specific diseases. The Company's corporate website is www.therapeuticsolutionsint.com, and our public forum is https://board.therapeuticsolutionsint.com/ 

¹ Correlation of Campbell Score With Suicidal Ideation - Full Text View - ClinicalTrials.gov
² Therapeutic Solutions International Spin-Off Campbell Neurosciences Announces Positive Clinical Trial Results for Campbell Score Blood Based Suicide Prediction | BioSpace

ir@tsoimail.com

 

View original content:https://www.prnewswire.com/news-releases/therapeutic-solutions-international-spin-off-campbell-neurosciences-initiates-pilot-implementation-of-campbell-score-with-california-concierge-medical--wellness-inc-301324925.html

SOURCE Therapeutic Solutions International

FAQ

What is the Campbell Score™ and its significance for TSOI?

The Campbell Score™ is a blood-based suicide prediction marker developed by TSOI, designed to assist psychiatrists in measuring suicide risk, with positive clinical trial results anticipating its use in medical practices.

When was the pilot implementation of the Campbell Score™ announced?

The pilot implementation of the Campbell Score™ was announced on July 2, 2021.

Who is involved in the development of the Campbell Score™?

The development of the Campbell Score™ involves Therapeutic Solutions International and Concierge Medical & Wellness Inc, under the leadership of Kalina O'Connor and Dr. James Veltmeyer.

What are the future plans for the Campbell Score™?

Future plans for the Campbell Score™ include seeking FDA clearance and insurance reimbursement following its pilot implementation.

What are the outcomes of the clinical trials for the Campbell Score™?

The clinical trials demonstrated that patients with suicidal tendencies received higher ratings on the Campbell Score™, indicating its potential effectiveness in suicide risk assessment.